These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection. Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167 [TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy. Busetto GM; Del Giudice F; Maggi M; De Marco F; Porreca A; Sperduti I; Magliocca FM; Salciccia S; Chung BI; De Berardinis E; Sciarra A World J Urol; 2021 Jun; 39(6):1869-1877. PubMed ID: 32681273 [TBL] [Abstract][Full Text] [Related]
4. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy. Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197 [TBL] [Abstract][Full Text] [Related]
5. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? Pepe P; Garufi A; Priolo G; Pennisi M World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628 [TBL] [Abstract][Full Text] [Related]
6. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy. Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296 [TBL] [Abstract][Full Text] [Related]
7. Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted Cores. Pepe P; Pepe L; Pennisi M; Fraggetta F Clin Genitourin Cancer; 2021 Aug; 19(4):305-308. PubMed ID: 33642223 [TBL] [Abstract][Full Text] [Related]
8. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study. Maggi M; Del Giudice F; Falagario UG; Cocci A; Russo GI; Di Mauro M; Sepe GS; Galasso F; Leonardi R; Iacona G; Carroll PR; Cooperberg MR; Porreca A; Ferro M; Lucarelli G; Terracciano D; Cormio L; Carrieri G; De Berardinis E; Sciarra A; Busetto GM Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922626 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. Otti VC; Miller C; Powell RJ; Thomas RM; McGrath JS BJU Int; 2019 Jan; 123(1):82-90. PubMed ID: 29804315 [TBL] [Abstract][Full Text] [Related]
10. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men. Hendriks RJ; van der Leest MMG; Israël B; Hannink G; YantiSetiasti A; Cornel EB; Hulsbergen-van de Kaa CA; Klaver OS; Sedelaar JPM; Van Criekinge W; de Jong H; Mulders PFA; Crawford ED; Veltman J; Schalken JA; Barentsz JO; van Oort IM Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1110-1119. PubMed ID: 33941866 [TBL] [Abstract][Full Text] [Related]
11. Confirmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassification rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy. Pepe P; Pepe L; Pennisi M; Fraggetta F Arch Ital Urol Androl; 2022 Sep; 94(3):270-273. PubMed ID: 36165468 [TBL] [Abstract][Full Text] [Related]
12. Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx? Rahnama'i MS; Bach C; Schulze-Hagen M; Kuhl CK; Vögeli TA Cancer Rep (Hoboken); 2021 Dec; 4(6):e1396. PubMed ID: 33931984 [TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA PET/CT evaluation in men enrolled in prostate cancer Active Surveillance. Pepe P; Pepe L; Tamburo M; Marletta G; Savoca F; Pennisi M; Fraggetta F Arch Ital Urol Androl; 2023 May; 95(2):11322. PubMed ID: 37212907 [TBL] [Abstract][Full Text] [Related]
14. Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer. Katzendorn O; von Klot CAJ; Mahjoub S; Faraj Tabrizi P; Harke NN; Tezval H; Hellms S; Hennenlotter J; Baig MS; Stenzl A; Seith F; Lafos M; Kuczyk MA; Rausch S; Peters I PLoS One; 2022; 17(8):e0271981. PubMed ID: 35960727 [TBL] [Abstract][Full Text] [Related]
15. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
16. Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports. Minnee P; Hessels D; Schalken JA; Van Criekinge W BMC Urol; 2019 Nov; 19(1):124. PubMed ID: 31783839 [TBL] [Abstract][Full Text] [Related]
17. How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy. Pepe P; Pennisi M; Fraggetta F Urology; 2020 Mar; 137():133-137. PubMed ID: 31758981 [TBL] [Abstract][Full Text] [Related]
18. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Pepe P; Garufi A; Priolo G; Pennisi M Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324 [TBL] [Abstract][Full Text] [Related]
19. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis. Sari Motlagh R; Yanagisawa T; Kawada T; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Huebner NA; Baltzer PA; Karakiewicz PI; Heidenreich A; Shariat SF Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):187-198. PubMed ID: 35414118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]